Companies: 10,795·Total market cap: $144.5T

XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTXNASDAQHealthcare● Active

$2.18

$-0.03(-1.36%)

Market Cap$607106

P/E Ratio—

52W High$7.05

52W Low$1.725

Avg Volume1.2M

Open$2.14

Beta0.67

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

XORTX Therapeutics Inc.（XRTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · XRTX · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-68.43Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield0.40%Dividend history

Shares Outstanding189,385Shares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 XORTX Therapeutics Inc. 数据

分析师预测—

盈利EPS $-14.20+48.27%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$2.7M▲ +15.79% YoY

202320242025

FY 2025EPS$-14.20▲ +48.27% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$2.8MEPS: $-68.43View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

XORTX Therapeutics Inc.

$2.18-1.36%$607,106 #2

Avenue Therapeutics, Inc.

$0.31-12.06%$1.0M #3

Dermata Therapeutics, Inc.

$1.21+2.54%$824,684 #4

PMGC Holdings Inc.

$1.59+3.25%$3.1M #5

GT Biopharma, Inc.

$0.43-2.57%$4.5M #6

Lexaria Bioscience Corp.

$0.65+1.51%$13.2M

股票表现

1D-1.36%

1W-1.36%

1M-21.86%

3M-6.84%

YTD-22.42%

1Y-51.12%

5Y-97.44%

关于 XORTX Therapeutics Inc.

CEOAllen Warren Davidoff

IPO DateSep 23, 2021

Employees2

CountryCA

Websitexortx.com

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insul…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

XORTX Therapeutics Inc.（XRTX）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 23, 2021 在 NASDAQ 上市。截至最近交易日，XRTX 股价为 $2.18，市值约为 $607,106。过去12个月累计回报 -51.12%，年初至今回报 -22.42%。

2025 财年 XORTX Therapeutics Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，XORTX Therapeutics Inc.（XRTX）股价为 $2.18，在 NASDAQ 上市，52周区间为 $1.73 – $7.05。

XRTX 最新股价XRTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议